Pendulum GLP-1 Probiotic uses live strains, while resM uses heat-inactivated L
Robert Kushner: We don't have that information
This raises theoretical concerns about oral contraceptive absorption
Barriers to initiating treatment may include delayed recognition of obesity as a disease by public health and medical organizations, provider biases regarding patients with obesity, lack of reimbursement leading to out-of-pocket costs to patients, inadequate training of providers, historical safety issues with AOMs, and perceptions of patients and their caregivers regarding the efficacy of AOMs [14,15,16,17]
Patients with Hashimoto's require careful monitoring as weight changes may affect levothyroxine requirements, and GLP-1 medications carry risks including pancreatitis and gallbladder disease
Until recently, therapeutic strategies for people with obesity were of limited efficacy 2 , with the main strategies for weight loss focused on lifestyle interventions, including diet and exercise 3
